Up a level |
Cristofanilli, M. and Slamon, D.J. and Ro, J. and Bondarenko, I. and Im, S-A. and Masuda, N. and Colleoni, M. and DeMichele, A. and Loi, S. and Verma, S. and Iwata, H. and Harbeck, N. and Loibl, S. and Andre´, F. and Puyana Theall, K. and Huang, X. and Giorgetti, C. and Huang Bartlett, C. and Turner, N.C. (2018) Overall survival (OS) with palbociclib plus fulvestrant in women with hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER22) advanced breast cancer (ABC): Analyses from PALOMA-3. Annals of Oncology, Vol.29 (Sapp.8). viii708-viii708. ISSN 0923-7534 (Print), 1569-8041 (Electronic)